AJP - Endo Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Endocrinol Metab 285: E272-E279, 2003. First published April 15, 2003; doi:10.1152/ajpendo.00409.2002
0193-1849/03 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
285/2/E272    most recent
00409.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (18)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gomez-Sanchez, E. P.
Right arrow Articles by Gomez-Sanchez, C. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gomez-Sanchez, E. P.
Right arrow Articles by Gomez-Sanchez, C. E.

Regulation of 11{beta}-hydroxysteroid dehydrogenase enzymes in the rat kidney by estradiol

Elise P. Gomez-Sanchez,1,2,4 Venkataseshu Ganjam,5 Yuan Jian Chen,5 Ying Liu,4 Ming Yi Zhou,4 Cigdem Toroslu,4 Damian G. Romero,2 Michael D. Hughson,3 Angela de Rodriguez,2 and Celso E. Gomez-Sanchez1,2,4

1Endocrine Section and Research Service, G. V. (Sonny) Montgomery Veterans Affairs Medical Center, 2Division of Endocrinology, and 3Department of Pathology, The University of Mississippi Medical Center, Jackson, Mississippi 39216; and Departments of 4Medicine and 5Veterinary Biomedical Sciences, University of Missouri-Columbia, Columbia, Missouri 65211

Submitted 16 September 2002 ; accepted in final form 6 April 2003

The 11{beta}-hydroxysteroid dehydrogenase (11{beta}HSD) type 1 (11{beta}HSD1) enzyme is an NADP+-dependent oxidoreductase, usually reductase, of major glucocorticoids. The NAD+-dependent type 2 (11{beta}HSD2) enzyme is an oxidase that inactivates cortisol and corticosterone, conferring extrinsic specificity of the mineralocorticoid receptor for aldosterone. We reported that addition of a reducing agent to renal homogenates results in the monomerization of 11{beta}HSD2 dimers and a significant increase in NAD+-dependent corticosterone conversion. Estrogenic effects on expression, dimerization, and activity of the kidney 11{beta}HSD1 and -2 enzymes are described herein. Renal 11{beta}HSD1 mRNA and protein expressions were decreased to very low levels by estradiol (E2) treatment of both intact and castrated male rats; testosterone had no effect. NADP+-dependent enzymatic activity of renal homogenates from E2-treated rats measured under nonreducing conditions was less than that of homogenates from intact animals. Addition of 10 mM DTT to aliquots from these same homogenates abrogated the difference in NADP+-dependent activity between E2-treated and control rats. In contrast, 11{beta}HSD2 mRNA and protein expressions were significantly increased by E2 treatment. There was a marked increase in the number of juxtamedullary proximal tubules stained by the antibody against 11{beta}HSD2 after the administration of E2. Notwithstanding, neither the total corticosterone and 11-dehydrocorticosterone excreted in the urine nor their ratio differed between E2- and vehicle-treated rats. NAD+-dependent enzymatic activity in the absence or presence of a reducing agent demonstrated that the increase in 11{beta}HSD2 protein was not associated with an increase in in vitro activity unless the dimers were reduced to monomers.

hypertension; aldosterone


Address for reprint requests and other correspondence: E. P. Gomez-Sanchez, Research Service, G. V. (Sonny) Montgomery VA Medical Center, 1500 E. Woodrow Wilson Dr. (151), Jackson, MS 39216 (E-mail: egomez-sanchez{at}medicine.umsmed.edu).




This article has been cited by other articles:


Home page
 J. Histochem. Cytochem.Home page
E. P. Gomez-Sanchez, M. T. Gomez-Sanchez, A. F. de Rodriguez, D. G. Romero, M. P. Warden, M. W. Plonczynski, and C. E. Gomez-Sanchez
Immunohistochemical Demonstration of the Mineralocorticoid Receptor, 11{beta}-Hydroxysteroid Dehydrogenase-1 and -2, and Hexose-6-phosphate Dehydrogenase in Rat Ovary
J. Histochem. Cytochem., July 1, 2009; 57(7): 633 - 641.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
J. W. Tomlinson, J. Finney, C. Gay, B. A. Hughes, S. V. Hughes, and P. M. Stewart
Impaired Glucose Tolerance and Insulin Resistance Are Associated With Increased Adipose 11{beta}-Hydroxysteroid Dehydrogenase Type 1 Expression and Elevated Hepatic 5{alpha}-Reductase Activity
Diabetes, October 1, 2008; 57(10): 2652 - 2660.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
J. Komiyama, R. Nishimura, H.-Y. Lee, R. Sakumoto, M. Tetsuka, T. J. Acosta, D. J. Skarzynski, and K. Okuda
Cortisol Is a Suppressor of Apoptosis in Bovine Corpus Luteum
Biol Reprod, May 1, 2008; 78(5): 888 - 895.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
K. Usa, R. J. Singh, B. C. Netzel, Y. Liu, H. Raff, and M. Liang
Renal interstitial corticosterone and 11-dehydrocorticosterone in conscious rats
Am J Physiol Renal Physiol, July 1, 2007; 293(1): F186 - F192.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
H. C. Thiesson, B. L. Jensen, C. Bistrup, P. D. Ottosen, A. D. McNeilly, R. Andrew, J. Seckl, and O. Skott
Renal sodium retention in cirrhotic rats depends on glucocorticoid-mediated activation of mineralocorticoid receptor due to decreased renal 11beta-HSD-2 activity
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2007; 292(1): R625 - R636.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2003 by the American Physiological Society.